CO-1bi

N/A

Report date: 2024/03/25 17:10:29

Base Information

Drug NameCO-1bi
Drug Alias NameCO-1bi
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCluster of differentiation 47 modulators
TargetsCluster of differentiation 47
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCaedo Oncology AS
China Registration ClassN/A

Develop Information

Active CompaniesCaedo Oncology AS
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A